Jen Kates
@jenkatesdc
Senior VP/Director, Global Health & HIV Policy, @KFF. Health policy, epidemics, data, & parenting. NYC born & raised, DC is now home.
ID: 121191859
http://kff.org/person/jennifer-kates/ 08-03-2010 18:30:00
10,10K Tweet
5,5K Followers
823 Following
Exciting news! Gilead Sciences has announced PURPOSE 2 trial interim results. 99.9% of cisgender men & gender-diverse people in the #lenacapavir group did not acquire #HIV. These results further strengthen the promise of lenacapavir for HIV prevention: gilead.com/news-and-pressā¦
"An injectable HIV-prevention drug is highly effective ā but wildly expensive" - see Benjamin Ryan's review on Gilead Sciences PURPOSE 2 results. w/ Jen Kates Amy Killelea AVAC Dr. Jirair Ratevosian nbcnews.com/feature/nbc-ouā¦
āThe incredible efficacy demonstrated in the PURPOSE 2 trial, the potential benefits of a twice-yearly injection, & the diversity of trial sites & participants show the impact that #lenacapavir for PrEP could have for people around the world"' via CNN edition.cnn.com/2024/09/12/heaā¦
Just Announced: At the request of the government of the Democratic Republic of the Congo (DRC), The Global Fund is supporting the country with US$9.5 million for its emergency mpox response in six of the highest transmission provinces. theglobalfund.org/en/news/2024/2ā¦
Both Gavi, the Vaccine Alliance and The Global Fund have just announced new #mpox efforts in the DRC/Africa.
šŗš¦ "#Ukraine keeps up the fight against #HIV while fighting a war" Check out this new NPR article featuring leading Ukrainian public health voices, including Andriy Klepikov who is an IAS Governing Council member & Executive Director of AlliancePublicHealth! npr.org/sections/goatsā¦